Science Explorer Interactive view Map
Company · Cambridge · ??

GV20 Therapeutics (United States)

gv20tx.comROR OpenAlex
Research works
4
fractional, all time
Citations
44
10.7 per fractional work
Top-10% rate
9.4%
record average 16.5%
Open access
66%
world 28%

Not ranked overall: GV20 Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does GV20 Therapeutics (United States) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Ferroptosis and cancer prognosis and Monoclonal and Polyclonal Antibodies Research.

Cancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksRNA modifications and ca…0RNA modifications and cancer: 0 fractional worksFerroptosis and cancer p…0Ferroptosis and cancer prognosis: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksEpigenetics and DNA Meth…0Epigenetics and DNA Methylation: 0 fractional worksCAR-T cell therapy research: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional worksCancer Research and Treatments: 0 fractional worksinterferon and immune responses: 0 fractional works
OncologyMolecular BiologyPulmonary and Respiratory MedicineRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
  2. 2 RNA modifications and cancer Molecular Biology 0 works
  3. 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Immune Cell Function and Interaction Immunology 0 works
  6. 6 Epigenetics and DNA Methylation Molecular Biology 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Bladder and Urothelial Cancer Treatments Surgery 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 interferon and immune responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.4%not open33.6%

World: 28% of research is openly available.

with international co-authors40.5%domestic only59.5%

World: 19% is written across borders.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.